Dr. Reddy's Laboratories Ltd (
) will begin trading ex-dividend on July 10, 2013. A cash dividend
payment of $0.2644 per share Shareholders who purchased RDY stock
prior to the ex-dividend date are eligible for the cash dividend
payment. This represents an 15.26% increase over the prior
The previous trading day's last sale of RDY was $36.77,
representing a -5.09% decrease from the 52 week high of $38.74 and
a 28.03% increase over the 52 week low of $28.72.
RDY is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). RDY's current earnings per share, an indicator of a company's
profitability, is $1.9. Zacks Investment Research reports RDY's
forecasted earnings growth in 2014 as 10.81%, compared to an
industry average of -7.5%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to RDY through an Exchange
Traded Fund [ETF]?
The following ETF(s) have RDY as a top-10 holding:
- EGShares Health Care GEMS ETF (
- First Trust Exchange-Traded Fund II First Trust BICK Index
The top-performing ETF of this group is HGEM with an increase of
4.71% over the last 100 days. It also has the highest percent
weighting of RDY at 4.95%.